Pharmatest Services Ltd, a Finnish CRO specialising in non-clinical pharmacological research services has signed a Master Service Agreement with Bayer Schering Pharma AG, Germany.
304 companies have used ILS to recruit investigators on 685 protocols.
In endoscopy, there have been attempts for many years to show doctors important additional information live on the endoscopy video to help them with their diagnosis. Now, for the first time, there is a technology at the threshold to the medical device market capable of delivering the relevant spectral information in real time.
PharmaCore, Inc., an experienced US-based contract research and manufacturing organization, announces a partnership with PharmaAdvance, a China based pharmaceutical contract research organization (CRO) providing services in chemistry and pharmacology, to extend PharmaCore's custom synthesis and contract research capabilities.
CTR specialises in the development of surface acoustic waves (SAW) sensors, which are suited to particularly demanding identification and measuring tasks. Now their gamma-ray resistance has been successfully tested: they endure 500kGy (Kilogray) without performance loss. Their upper-load limit is currently unknown.
By Birgit Rader-Brunner.
Scientific cancer research is based on the microscopic monitoring of cells and tissue. Now, methods of spectral image processing improve the image contrast and support medical diagnostics via software solutions.
Metrohm is pleased to introduce the Metrosep A Supp 16 – a new generation of high-capacity anion exchange columns featuring an inner diameter of only 2mm.
ModiQuest Research is a young and dynamic biotechnology company that is based in Nijmegen, the Netherlands. ModiQuest Research discovers, develops, and markets new tools and technologies for use in human diagnostics and therapeutics.
BINDER GmbH has nine new employees, who will be completing their training starting today. Manufacturing simulation and climate chambers for industry and science for 25 years, the family company currently employs 30 trainees.
Australian health care company Prima BioMed Ltd (ASX: PRR) (Prima) is pleased to announce that its subsidiary company, Oncomab Pty Ltd (Oncomab), has entered into a licensing agreement for the development of a Cripto-1 cancer monoclonal antibody (mAB) with leading Dutch pharmaceutical development company Bioceros.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.